Gene Delivery and Gene Editing (Focus Group - GDGE)
mRNA therapeutics have captured global attention, yet their application in cardiovascular diseases (CVDs) remains underexplored. A critical barrier lies in the development of advanced delivery systems capable of ensuring low immunogenicity and precise, targeted mRNA delivery [1]. To address this gap, we present an innovative theranostic platform using phase-change perfluorocarbon nanodroplets (PFC NDs), designed to integrate multimodal imaging (ultrasound or MRI), with acoustically triggered mRNA release for localised, enhanced transfection.
Xiaowei Wang, PhD
Professor
University of Melbourne
Melbourne, Victoria, Australia